If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Holding(s) in Company

8 Dec 2020 12:47

RNS Number : 9483H
Nationwide Building Society
08 December 2020
 

 

8 December 2020

Nationwide Building Society

(the "Society")

Core Capital Deferred Shares

(GB00BBQ33664)

(the "CCDS")

NOTICE IS HEREBY GIVEN by the Society, pursuant to DTR 5.8.12R, that the Society received on 8 December 2020 a TR-1 form in respect of the CCDS from Citivic Nominees Limited (the "Nominee"). 

The TR-1 form confirmed that the Nominee is the registered holder of all of the 10,555,500 CCDS issued by the Society, comprising the 5,500,000 CCDS issued on 6 December 2013, the 5,000,000 further CCDS issued on 14 September 2017, the 28,000 further CCDS issued on 17 June 2020 and the 27,500 further CCDS issued on 8 December 2020.

Interests in the CCDS are held by beneficial owners through accounts with Euroclear Bank SA/NV and Clearstream Banking S.A. and, whilst so held, the legal title to all of the CCDS is registered in the name of the Nominee as nominee for those clearing systems. The members' rights attaching to the CCDS so held will be held by the Nominee, who will be entitled to exercise (without following instructions given in writing or by electronic means) the voting and other members' rights attributable to all those CCDS so held.

The Nominee, in its capacity as a member of the Society, shall have only one vote (regardless of the number of CCDS held by it and regardless also of the size and number of other relevant investments or interests (if any) conferring membership rights which the Nominee may have in the Society) on any resolution put to members of the Society generally.

Given the difficulty of casting the single vote attaching to the CCDS at a general meeting of the members of the Society in a manner which reflects the views of all the investors holding CCDS through a clearing system and the relative insignificance of that vote in the context of all the votes which may be cast by members of the Society, the Nominee has informed the Society that it does not intend to exercise its vote insofar as such vote relates to its holding of CCDS.

For further information, please contact

Nationwide Building Society

One Threadneedle Street

London EC2R 8AW

Charlie Wood

Head of Financial Risk Strategy & Investor Relations

Telephone: +44 (0) 7500 999 612

Email: Charles.Wood@nationwide.co.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLBDBDDXSGDGGI
Date   Source Headline
30th Jun 20264:30 pmRNSAnnual Report - Nationwide Covered Bonds LLP
30th Jun 20261:04 pmRNSAdmission to Trading
26th Jun 20261:52 pmRNSPublication of Final Terms
25th Jun 202612:21 pmRNSAdmission to Trading
23rd Jun 202612:03 pmRNSPublication of Final Terms
23rd Jun 202611:04 amRNSAdmission to Trading
19th Jun 20264:43 pmRNSPublication of Final Terms
15th Jun 20261:30 pmRNSNotice to Covered Bondholders
15th Jun 202612:40 pmRNSPublication of a Supplementary Prospectus
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.